Skip to main content
رجوع
Watch Compare

NP Life Sciences Health Industry Group Inc.

جودة البيانات: 100%
ACAT
OTC Services Educational Services
KWD 1.00
▼ KWD 9.00 (-90.00%)
القيمة السوقية: 77.21 M
السعر
KWD 1.00
القيمة السوقية
77.21 M
نطاق اليوم
KWD 1.00 — KWD 1.00
نطاق 52 أسبوعًا
KWD 0.54 — KWD 10.00
حجم التداول
2,500
فتح KWD 1.00
متوسط 50 يوم / 200 يوم
KWD 10.00
90.00% below
متوسط 50 يوم / 200 يوم
KWD 6.07
83.54% below

Quick Summary

النقاط الرئيسية

ROE of 58.71% indicates high profitability
Generating 55,238.0 in free cash flow
P/E of 2660.93 — premium valuation
Cash machine — converts 190.36% of earnings into free cash flow
ROIC of 34.16% — excellent capital efficiency

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-38.04%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
58.71%
أعلى من متوسط القطاع (-15.74%)
ROIC34.16%
Net Margin14.46%
Op. Margin25.80%

الأمان

Debt / Equity
N/A
Current RatioN/A
Interest Coverage12943.00

التقييم

PE (TTM)
2660.93
أعلى من متوسط القطاع (-1.17)
P/B Ratio2433.04
EV/EBITDA1489.81
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Services (502 نظير)
المقياس السهم وسيط القطاع
P/E 2660.9 -1.2
P/B 2433.0 1.4
ROE % 58.7 -15.7
Net Margin % 14.5 -18.3
Rev Growth 5Y % — 4.2
D/E — 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) -38.04% Revenue Growth (3Y) 70.73%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 200,634.0 Net Income (TTM) 29,018.0
ROE 58.71% ROA 24.24%
Gross Margin N/A Operating Margin 25.80%
Net Margin 14.46% Free Cash Flow (TTM) 55,238.0
ROIC 34.16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage 12943.00 Asset Turnover 1.68
Working Capital N/A Tangible Book Value 31,736
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2660.93 Forward P/E N/A
P/B Ratio 2433.04 P/S Ratio 384.85
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 1489.81 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.07%
Market Cap 77.21 M Enterprise Value 77.13 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 190.36%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Revenue 102,002.0 164,621.0 34,992.0 15,000.0 43,000.0
Net Income -18,856.0 -2,935.0 -65,677.0 -131,065.0 -108,827.0
EPS (Diluted) — 0.00 — — —
Gross Profit — — — — —
Operating Income -18,855.0 -690.0 -65,681.0 -131,091.0 -108,859.0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense -1.0 645.0 — — —
Income Tax — 1,600.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Total Assets 127,784.0 76,864.0 38,411.0 118,611.0 250,097.0
Total Liabilities 108,468.0 60,483.0 239.0 14,762.0 15,183.0
Shareholders' Equity 19,316.0 16,381.0 38,172.0 103,849.0 234,914.0
Total Debt — — — — —
Cash & Equivalents 121,859.0 70,614.0 27,986.0 118,611.0 242,933.0
Current Assets — — — — —
Current Liabilities — 38,121.0 — — —